The Pink Sheet: Part D Point-Of-Sale Rebates Losing Appeal? CBO Confirms Big Cost To Medicare

“This score strikes the third blow to the drug makers’ long-running, multi-million dollar campaign to shift blame for their own prices onto the health plans and…PBMs that negotiate discounts and rebates to reduce costs. For policymakers, this should be a ‘three strikes and you’re out’ moment,” the group said in a release.